ADVANZ PHARMA is a global pharmaceutical company that is committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality niche, established medicines.
As the Covid-19 outbreak continues to evolve rapidly, ADVANZ PHARMA takes the potential impact of the Coronavirus extremely seriously and has put in place all appropriate measures and contingency plans to minimize any risk to the supply of our medicines.
At present, we are experiencing exceptionally high demand for certain medicines. Ensuring supply continuity is of paramount importance to ADVANZ PHARMA and we are doing everything we can, working closely with our manufacturers, regulatory bodies and other relevant agencies, to ensure patients can continue to access vital medicines at this challenging time.
Our other primary focus continues to be the health and wellbeing of our colleagues, our customers and doing our part to help protect our patients and communities with all ADVANZ PHARMA employees who can do so continuing to work remotely. This has no impact on our business and all our sites and business functions continue to remain operational. Anyone who wishes to contact us at ADVANZ PHARMA can do so via the usual channels.
However, the situation remains incredibly dynamic and things can change quickly, we therefore continue to monitor the situation very closely.
About ADVANZ PHARMA
ADVANZ PHARMA operates an international specialty pharmaceutical business with a diversified portfolio of more than 200 branded and unbranded products, and sales in more than 90 countries, and going forward, is focused on becoming the leading platform for niche-established medicines, with advanced commercial capabilities throughout Western Europe. ADVANZ PHARMA’s registered office is in Jersey, Channel Islands. The Company operates globally through its subsidiaries in Sydney, Australia; Mumbai, India; Dublin, Ireland; Helsingborg, Sweden; Chicago, United States; and it's head office in London, England.